Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?

J Cosmet Dermatol. 2023 Sep;22(9):2380-2381. doi: 10.1111/jocd.15755. Epub 2023 Jun 29.

Authors

Giulia Ciccarese¹, Mario Mastrolonardo¹, Gaetano Serviddio², Francesco Drago³

Affiliations

¹ Section of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
² Liver Unit, Department of Medical and Surgical Sciences, C.U.R.E. (University Centre for Liver Disease Research and Treatment), University of Foggia, Foggia, Italy.
³ Section of Dermatology, Department of Health Sciences, University of Genoa, IRCCS - Ospedale Policlinico San Martino, Genoa, Italy.

PMID: 37382032
DOI: 10.1111/jocd.15755

No abstract available

Keywords: COVID-19 vaccination; maculopapular eruptions; pityriasis rosea; pityriasis rosea-like eruptions.

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Drug Eruptions* / diagnosis
Drug Eruptions* / etiology
Humans
Pityriasis Rosea* / diagnosis
Pityriasis Rosea* / etiology
Vaccination

Substances

COVID-19 Vaccines